MORGAN STANLEY PLC/CALL/STRYKER CORP./450/0.1/20.09.24 Share Price

Warrant

DE000ME9BQG1

Market Closed - Börse Stuttgart 19:11:53 10/05/2024 BST
0.1 EUR +1.01% Intraday chart for MORGAN STANLEY PLC/CALL/STRYKER CORP./450/0.1/20.09.24
Current month-15.97%
1 month-41.18%
Date Price Change Volume
10/05/24 0.1 +1.01% 0
09/05/24 0.099 -1.00% 0
08/05/24 0.1 -0.99% 0
07/05/24 0.101 0.00% 0
06/05/24 0.101 -1.94% 0

Delayed Quote Börse Stuttgart

Last update May 10, 2024 at 07:11 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
Issuer Morgan Stanley
WKN ME9BQG
ISINDE000ME9BQG1
Date issued 27/02/2024
Strike 450 $
Maturity 20/09/2024 (132 Days)
Parity 10 : 1
Emission price 0.24
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.38
Lowest since issue 0.083
Spread 0.037
Spread %27.21%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus